Regen BioPharma Inc Business Finance Contracts & Agreements
98 Contracts & Agreements
- Note Agreements (95 contracts)
- Purchase Agreements (2)
- Registration Rights Agreements (1)
- Convertible Note 5 (Filed With SEC on September 25, 2023)
- Convertible Note Zander Therapeutics, Inc (Filed With SEC on September 25, 2023)
- Convertible Note 4 (Filed With SEC on September 25, 2023)
- Convertible Note 3 (Filed With SEC on September 25, 2023)
- Convertible Note 2 (Filed With SEC on September 25, 2023)
- Convertible Note 1 (Filed With SEC on September 25, 2023)
- Registration Rights Agreement (Filed With SEC on September 18, 2023)
- Purchase Agreement (Filed With SEC on September 18, 2023)
- Convertible Note 1 (Filed With SEC on April 13, 2023)
- Convertible Note 2 (Filed With SEC on April 13, 2023)
- Convertible Note 3 (Filed With SEC on April 13, 2023)
- Convertible Note 4 (Filed With SEC on April 13, 2023)
- Convertible Note Zander Therapeutics, Inc (Filed With SEC on April 13, 2023)
- Convertible Note 5 (Filed With SEC on April 13, 2023)
- Promissory Note (Filed With SEC on September 24, 2021)
- Form of Amendment Convertible Note (Filed With SEC on August 29, 2019)
- Form of Convertible Note $20,331 (Filed With SEC on August 29, 2019)
- Form of Convertible Note $14,819 (Filed With SEC on August 29, 2019)
- Form of Convertible Note $100,000 (Filed With SEC on August 29, 2019)
- Form of Convertible Note 50,000 (Filed With SEC on August 29, 2019)
- Form of Note Receivable $50,000 (Filed With SEC on February 12, 2019)
- Form of Convertible Note $50,000 (Filed With SEC on February 12, 2019)
- Form of Convertible Note $50,000 (Filed With SEC on February 12, 2019)
- Form of Note Receivable $63,000 (Filed With SEC on February 12, 2019)
- Form of Convertible Note $75,000 (Filed With SEC on February 12, 2019)
- Form of Convertible Note $63,000 (Filed With SEC on February 12, 2019)
- Form of Convertible Note $63,000 (Filed With SEC on February 12, 2019)
- CONVERTIBLE PROMISSORY NOTE (Filed With SEC on October 4, 2018)
- Form of Convertible Note $11,500 (Filed With SEC on August 6, 2018)
- Form of Convertible Note $114,000 (Filed With SEC on August 6, 2018)
- Unit Purchase Agreement $50,000 (Filed With SEC on May 14, 2018)
- Convertible Note $115,000 (Filed With SEC on May 14, 2018)
- Form of Convertible Note $70,000 (Filed With SEC on May 14, 2018)
- Form of Convertible Note $30,000 (Filed With SEC on May 14, 2018)
- Form of Convertible Note $25,000 (Filed With SEC on May 14, 2018)
- CONVERTIBLEPROMISSORY NOTE (Filed With SEC on February 6, 2018)
- CONVERTIBLEPROMISSORY NOTE (Filed With SEC on February 6, 2018)
- REGENBIOPHARMA, INC. 8%CONVERTIBLE REDEEMABLE NOTE DUE DECEMBER 6, 2018 BACKEND (Filed With SEC on January 5, 2018)
- REGENBIOPHARMA, INC. 8%CONVERTIBLE REDEEMABLE NOTE DUE DECEMBER 6, 2018 (Filed With SEC on January 5, 2018)
- CONVERTIBLEPROMISSORY NOTE (Filed With SEC on January 5, 2018)
